Literature DB >> 35342302

Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma.

Yajun Chen1, Yiming Liu1, Menghao Wang1.   

Abstract

Background: Pancreatic adenocarcinoma (PAAD) is a highly malignant tumor with an extremely poor prognosis. Pyroptosis has been demonstrated to play an important role in tumor prognosis. However, the expression of pyroptosis-related genes in PAAD and their correlations with prognosis remains unclear.
Methods: In this study, the 36 pyroptosis-related genes that were differentially expressed between normal pancreatic tissues and PAAD tissues were identified via the "limma" R package. Based on these differentially expressed genes (DEGs), a five-gene signature was established by applying the least absolute shrinkage and selection operator Cox regression in the TCGA cohort and was validated in the GEO cohort. The Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses of DEGs based on the risk model indicated that immune-associated biological processes and pathways were enriched. In vivo, we detected the expressions of CASP4 and CHMP4C by immunohistochemistry in tumor tissues and adjacent normal tissues. In vitro, we silenced CASP4 and CHMP4C to explore their effects on pancreatic cancer cells.
Results: PAAD patients in the low-risk group showed significantly higher survival possibilities than those in the high-risk group. The expressions of CASP4 and CHMP4C in tumor tissue were higher than those in the adjacent normal tissues in vivo. The knockdown of CASP4 significantly inhibited the invasion and migration but not the proliferation of PANC-1 cells. The knockdown of CHMP4C obviously inhibited the proliferation, migration, and invasion of PANC-1 cells.
Conclusion: Pyroptosis-related genes play important roles in predicting the prognosis of PAAD, and CASP4 and CHMP4C affect the metastasis of PAAD.
© 2022 Chen et al.

Entities:  

Keywords:  CASP4; CHMP4C; pancreatic adenocarcinoma; prognosis; pyroptosis; signature

Year:  2022        PMID: 35342302      PMCID: PMC8943832          DOI: 10.2147/IJGM.S353849

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  38 in total

Review 1.  Pancreatic cancer.

Authors:  Jonathan D Mizrahi; Rishi Surana; Juan W Valle; Rachna T Shroff
Journal:  Lancet       Date:  2020-06-27       Impact factor: 79.321

2.  Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.

Authors:  Suneel D Kamath; Aparna Kalyan; Sheetal Kircher; Halla Nimeiri; Angela J Fought; Al Benson; Mary Mulcahy
Journal:  Oncologist       Date:  2019-11-19

3.  Inflammatory caspases are innate immune receptors for intracellular LPS.

Authors:  Jianjin Shi; Yue Zhao; Yupeng Wang; Wenqing Gao; Jingjin Ding; Peng Li; Liyan Hu; Feng Shao
Journal:  Nature       Date:  2014-08-06       Impact factor: 49.962

Review 4.  Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance.

Authors:  Thatcher Heumann; Nilofer Azad
Journal:  Cancer Metastasis Rev       Date:  2021-09-30       Impact factor: 9.264

5.  Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores.

Authors:  Xing Liu; Zhibin Zhang; Jianbin Ruan; Youdong Pan; Venkat Giri Magupalli; Hao Wu; Judy Lieberman
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

6.  Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.

Authors:  Eileen M O'Reilly; Do-Youn Oh; Neesha Dhani; Daniel J Renouf; Myung Ah Lee; Weijing Sun; George Fisher; Aram Hezel; Shao-Chun Chang; Gordana Vlahovic; Osamu Takahashi; Yin Yang; David Fitts; Philip Agop Philip
Journal:  JAMA Oncol       Date:  2019-10-01       Impact factor: 31.777

7.  Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells.

Authors:  Shu-Li Lin; Mei Wang; Qing-Qing Cao; Qing Li
Journal:  FEBS Open Bio       Date:  2020-05-30       Impact factor: 2.693

8.  A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma.

Authors:  Xin-Yu Li; Lu-Yu Zhang; Xue-Yuan Li; Xi-Tao Yang; Li-Xin Su
Journal:  Front Oncol       Date:  2021-08-17       Impact factor: 6.244

Review 9.  Cell death in pancreatic cancer: from pathogenesis to therapy.

Authors:  Xin Chen; Herbert J Zeh; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-30       Impact factor: 46.802

View more
  1 in total

1.  Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes.

Authors:  Canrong Li; Cha Lin; Xiaoduo Xie
Journal:  J Oncol       Date:  2022-06-20       Impact factor: 4.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.